SUNOSI® (Solriamfetol) Pregnancy Registry
Key facts
- Where
- Morrisville and Wilmington, United StatesSee the 2 sites
Where in United States
- Evidera, a PPD business unitMorrisville, United StatesContact: Study DirectorTaking people
- PPD, Inc.Wilmington, United StatesContact: Study DirectorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Axsome Therapeutics, Inc.
- Trial code
- NCT06413420
- Record updated
- 5 October 2026
- Original description
The SUNOSI (solriamfetol) Pregnancy Registry is a US- and Canada-based prospective, observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea (OSA).Read full original descriptionShow less
SUNOSI® (Solriamfetol) Pregnancy Registry: An Observational Study on the Safety of Solriamfetol Exposure in Pregnant Women and Their Offspring
The SUNOSI (solriamfetol) Pregnancy Registry is a US- and Canada-based prospective, observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea (OSA).
Inclusion: Pregnant women of any age; Diagnosed with narcolepsy or obstructive sleep apnea OR has taken solriamfetol or other wake promoting medications or stimulants during pregnancy or in the relevant exposure window before conception; Resident of the US or Canada; Provides written informed consent to participate in the study; Authorization for her HCP(s) to provide data to the registry.
Exclusion: Occurrence of pregnancy outcome prior to first contact with the registry coordination center (RCC).